Nexalin Technology, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for NXL, updated each market day.
NXL AI Sentiment
AI sees no strong directional signal for Nexalin Technology, Inc. Common Stock stock over the next 10 market days.
Prediction date: Sept. 17, 2026
Exact scores are in the SharePreds app
The precise prediction score for this stock, with buy and sell targets and a stop loss, updated every market day.
About Nexalin Technology, Inc. Common Stock
Nexalin Technology Inc designs and develops neurostimulation products and bioelectronic medical technology to treat anxiety and insomnia without drugs or psychotherapy. The Company has developed the Generation 1 (Gen 1) medical device, a cranial electrotherapy stimulation (CES) device classified by the U.S. Food and Drug Administration (FDA) as a Class II device. The Company operates as a single operating and reportable segment, focused on the design and development of innovative neurostimulation products. The Company focuses on treating mental health conditions without reliance on drugs or psychotherapy. Geographically, it generates sales in the USA and China, with China generating the maximum sales.
Sector
Exchange
Market Cap
$4,229,276
Cap Tier
Employees
8
Headquarters
HOUSTON, TX
Listed Since
Sept. 16, 2022
Website
NXL Sentiment Trend: Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
NXL Volatility
Nexalin Technology, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings: this can present both opportunity and risk for traders.
